Case Study

Product & Process Transfer of a Low Solubility Compound with 6 year OTIF >95%

Format: PDF file | Document type: Case Study

Product & Process Transfer of a Low Solubility Compound with 6 year OTIF >95%

Alkermes, through the merger with Elan Drug Technologies,to form Alkermes plc,has been developing and manufacturing commercial scale solid oral dosage products for over 40 years.This case study demonstrates the successful transfer of alow solubility compound into one of our manufacturing sites and achieving as a result, an OTIF (On-Time-In-Full) consistently over 95%.

Related resources from Alkermes Contract Pharma Services

Show more

Supplier info centre